Company Filing History:
Years Active: 1997
Title: John Hamman: Innovator in Thrombin Activation
Introduction
John Hamman, based in Baltimore, MD, is a notable inventor recognized for his contributions to the medical field, particularly in the activation of prothrombin. With one patent to his name, his work focuses on advancing methods that can have significant implications in blood coagulation processes.
Latest Patents
Hamman's patent, titled "Method for activating prothrombin to thrombin," presents a refined technique for converting prothrombin into thrombin. This patent outlines a prothrombin complex composition containing essential factors such as prothrombin, Factors V, VII, IX, and X, as well as phospholipid. The process involves two critical steps: first, cold-incubating the composition with calcium ions at specified pH and temperature conditions to activate Factor VII, and second, incubating the mixture further to activate prothrombin into thrombin. This innovative method holds promise for improving therapeutic applications in hematology.
Career Highlights
John Hamman currently works at the New York Blood Center, Inc., where he applies his expertise in blood-related research. This institution is renowned for its contributions to advancing medical science and developing critical techniques that save lives. Hamman's work is pivotal within this context, reflecting the center's commitment to fostering innovative solutions in transfusion medicine.
Collaborations
Throughout his career, Hamman has collaborated with esteemed colleagues such as Jinsheng Zou and Gerard Marx. These partnerships enhance the research environment, leading to the exploration of new ideas and techniques that contribute to their shared mission in advancing medical science.
Conclusion
John Hamman's work exemplifies the dedication and innovation inherent in the field of biochemistry and hematology. His patent on the method for activating prothrombin to thrombin underscores the importance of research in developing effective medical treatments. Through his role at the New York Blood Center, he continues to impact the medical community positively, collaborating with fellow researchers to push the boundaries of scientific knowledge and improve patient outcomes.